Menu
Recruiting NCT07102823

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease

— Observational Chronic Obstructive Pulmonary Disease (COPD) Pulmonary Hypertension

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hypertension. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Austria, Switzerland, United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease - a Retrospective Multi-center Data Analysis

Overview

Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension

Primary outcome measures

  • Severe Pulmonary Hypertension (PH) [Time frame: at inclusion]
  • all-cause mortality [Time frame: Until 2026]

Eligibility criteria

Inclusion criteria

  • clinical diagnosis of COPD
  • right heart catheterization including mPAP (Mean Pulmonary Artery Pressure), PVR (Pulmonary Vascular Resistance), PAWP (Pulmonary Artery Wedge Pressure), CO (cardiac output)
  • age >= 18 years

Exclusion criteria

  • pediatric patients
  • no COPD or no RHC

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Austria · 1 center
  • Medical University of Graz — Graz
Switzerland · 1 center
  • University of Zurich — Zurich
United Kingdom · 1 center
  • University of Sheffield — Sheffield

Identifiers

NCT: NCT07102823 · 35-272ex22/23

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗